Philip Morris International (PMI) Announces Filing of Application for I
LAUSANNE, Switzerland -- (BUSINESS WIRE) --Philip Morris International Inc. ...
2016-12-07
文传商讯
U.S. FDA approves Jardiance (empagliflozin) tablets to reduce the risk
First and only type 2 diabetes treatment approved to reduce cardiovascular d...
2016-12-07
文传商讯
Early Data Demonstrate Clinical Activity of Acalabrutinib in Difficult-
Phase I/II trial findings add to growing body of data on acalabrutinib clini...
2016-12-06
文传商讯
New Data Show High Adherence Rates with Pradaxa (dabigatran etexilate)
New analysis of GLORIA™-AF Registry Program includes data from nearly ...
2016-12-06
文传商讯
Takeda and Seattle Genetics Report Positive Phase 3 ALCANZA Clinical Tr
– Data will be presented in an oral session at the annual American Soc...
2016-12-06
文传商讯
Boehringer Ingelheim and China Southeast University collaborate to deve
360 million people worldwide suffer from disabling hearing loss with no effe...
2016-12-01
文传商讯
NINLARO™ (ixazomib) Receives Conditional Approval from the Europe
Approval Based on TOURMALINE-MM1 Study Results, Which Demonstrated Statistic...
2016-11-29
文传商讯
Global Cloud Xchange Announces Deployment of Cumulous Network to Boost
Delivery of this new infrastructure marks a major step forward in provisioni...
2016-11-24
文传商讯
Boehringer Ingelheim welcomes central role of LAMA/LABA therapy within
• Pharmacologic treatment recommendations are tailored to patients'...
2016-11-18
文传商讯
Patient enrolment completed for RE-DUAL PCI study assessing dabigatran
Over 2,700 atrial fibrillation (AF) patients undergoing a percutaneous coron...
2016-11-16
文传商讯
